Sinovac Biotech Ltd.

NASDAQ: SVA · Real-Time Price · USD
6.47
0.00 (0.00%)
At close: Feb 11, 2025, 6:18 AM

Sinovac Biotech Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year Q1 2024 Q3 2023 Q1 2023 Q3 2022 Q1 2022 Q3 2021 Q1 2021
Period Ending Dec 31, 2023 Jun 30, 2023 Dec 31, 2022 Jun 30, 2022 Dec 31, 2021 Jun 30, 2021 Dec 31, 2020
Net Income
-470.56M 130.78M 3.47B 8.95B 8.66B 5.3B 185.18M
Depreciation & Amortization
223.58M 240.75M 225.44M 163.22M 87.06M 19.83M 4.04M
Stock-Based Compensation
n/a n/a n/a n/a 8.7M 9.45M 10.2M
Other Working Capital
-216.09M -1.33B -1.78B -210.96M 1.14B 1.61B 356.77M
Other Non-Cash Items
-1.07B 356.84M 2.66B 7.82B 6.58B 4.24B 8.32M
Deferred Income Tax
9.15M -115.13M 252.98M 249.26M 256.36M -81.06M -11.23M
Change in Working Capital
917.53M -1.08B -1.17B -1.26B 753.35M 840.23M 282.8M
Operating Cash Flow
257.79M -696.38M 5.61B 14.54B 15.85B 9.58B 479.31M
Capital Expenditures
-295.68M -531.99M -746.14M -1.04B -842.15M -568.51M -127.65M
Cash Acquisitions
44K 645K 728K 775K 172K 52K n/a
Purchase of Investments
-4.93B -18.42B -16.22B -24.03B -8.99B -4.54B -180.94M
Sales Maturities Of Investments
12.38M 10.34B 11.35B 18.46B 6.62B 1.6B 103.81M
Other Investing Acitivies
n/a n/a n/a n/a -161K -149K -144K
Investing Cash Flow
-5.22B -8.61B -5.62B -6.61B -3.21B -3.51B -204.76M
Debt Repayment
n/a n/a n/a n/a 9.03M 27.07M 33M
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a -1.88B -1.88B -1.88B n/a n/a
Other Financial Acitivies
-329.16M -24.23M -232.19M -9.09M 532.88M 526.85M 557.56M
Financial Cash Flow
-329.16M -24.23M -2.11B -1.88B -1.33B 555.92M 592.57M
Net Cash Flow
-5.59B -9.97B -2.57B 6.71B 12.37B 7.58B 894.33M
Free Cash Flow
-37.89M -1.23B 4.86B 13.5B 15.01B 9.02B 351.66M